SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences is trending as investors react to a recent SEC filing regarding executive change-of-control agreements, which the community is widely interpreting as a strategic precursor to a potential buyout. The stock is seeing significant volatility fueled by extreme short-squeeze conditions, including surging borrow fees and a large trapped short position ahead of an anticipated clinical readout for its flagship oncology asset.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is facing intense volatility and heavy selling pressure as investors grapple with a structural decline, a surprise CFO transition, and deep uncertainty heading into earnings. The community remains sharply divided, with some betting on a generational value play backed by iconic brand status, while others fear a continued downtrap driven by persistent competition and weak guidance.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as the market anticipates key catalysts, including the upcoming release of five-year open-label extension data for its Duchenne muscular dystrophy candidate and a pivotal court hearing regarding its commercial distribution rights. The community is actively discussing the potential for a broad label expansion and the strategic path toward independent commercialization as they monitor legal developments and progress toward an August PDUFA date.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is seeing intense volatility and bearish sentiment as the community debates the sustainability of its debt-fueled Bitcoin acquisition strategy amid a prolonged market downturn. Investors are sharply divided, with many expressing concern over potential liquidity risks and dividend obligations while others view the current price action as a generational buying opportunity.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is experiencing high volatility as investors weigh fundamental performance against technical pressure, with the community actively debating whether the stock is a bargain at current levels or trapped in a sustained structural decline. Many traders are focused on the stock's struggle to reclaim key support levels while speculating on the potential impact of share buybacks and a possible rotation from high-flying AI names back into established tech leaders.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is experiencing significant volatility and social media attention as retail investors mobilize to drive a short squeeze, hoping to capitalize on high short interest and undervaluation narratives. The community is actively debating the sustainability of the price action, with many encouraging others to hold their shares and resist pressure from short sellers.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros shares are trending sharply lower as investors react to a negative CHMP opinion on narsoplimab in the EU, though the community remains focused on the companys intent to appeal through an expert panel. While some express frustration with management communication, many long-term shareholders are actively discussing the U.S. FDA-approved product's potential and the upcoming path to regulatory reversal as a core value proposition.

Groupon, Inc. engages in the global scaled two-sided marketplace that connects consumers to merchants. It operates through the North America and International geographical segments. The company was founded by Andrew D. Mason, Eric Paul Lefkofsky, and Bradley A. Keywell in October 2008 and is headquartered in Chicago, IL.

Groupon Inc

Groupon is trending as investors bet on a potential short squeeze, fueled by high short interest and aggressive company-led share buybacks. The community is actively debating the stock's fundamental turnaround and the impact of the newly appointed COO, with many traders drawing parallels to other high-profile squeeze plays.

ON Semiconductor Corp. engages in the provision of intelligent power and sensing solutions with a primary focus on automotive and industrial markets. It operates through the following segments: Power Solutions Group (PSG), Analog and Mixed-Signal Group (AMG), and Intelligent Sensing Group (ISG). The PSG segment offers discrete, module, and integrated semiconductor products that perform multiple application functions, including power switching, signal conditioning, and circuit protection. The AMG segment designs and develops analog, mixed-signal, power management integrated circuits, sensor interface devices, power conversion, signal chain, and voltage regulation devices. The ISG focuses on the design and development of complementary metal oxide semiconductor image sensors, image signal processors, single photon detectors, including silicon photomultipliers, single photon avalanche diode arrays, and short-wavelength infrared products, as well as actuator drivers for autofocus and image stabilization. The company was founded on July 4, 1999 and is headquartered in Scottsdale, AZ.

ON Semiconductor Corp.

ON Semiconductor is trending due to the announcement of a $6 billion share repurchase program, which has sparked investor interest and fueled discussions regarding the company's valuation and long-term outlook. Community sentiment is mixed, with some traders viewing the buyback as a sign of management's confidence and an opportunity for value, while others remain skeptical, focusing on broader automotive market headwinds and the stock's recent performance.

TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA.

Transmedics Group Inc

Transmedics Group is trending as investors react to a significant post-earnings volatility, with the community actively debating whether the decline is a temporary margin squeeze driven by aggressive infrastructure expansion or a signal of structural revenue concerns. While short-term sentiment remains cautious due to technical selling and broader sector headwinds, long-term investors are highlighting strong flight data and the company's expanding market share as core pillars of the ongoing growth thesis.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

AI, Biotech, And Healthcare Catalysts Drive Momentum

Several emerging public companies are attracting attention as artificial intelligence, healthcare innovation, medical technology, and international commercialization strategies continue converging across the market. From AI-powered drug discovery and regenerative medicine expansion to precision dermatology and medical device innovation, recent developments highlight how smaller companies are positioning themselves around some of the fastest-growing sectors in healthcare and technology. $TGNT, $NXTS, $AZTR, $ADTX, $TNON, $PFE

Biotech And AI Stocks Deliver Fresh Catalysts, as Investors Swarm into Growth Stories

Today's market action highlighted a familiar theme across the small-cap landscape: investors continue searching for transformative growth stories amid a market increasingly driven by company-specific catalysts. $TGNT, $TOVX, $MGNI, $PPCB, $MASK

AI Gold Rush and Global Healthcare Deals Erupt

Investor attention continues shifting toward companies positioned at the intersection of artificial intelligence, biotechnology, defense technology, healthcare infrastructure, and digital transformation. $TGNT, $NCRA, $FRSX, $VWAV, $WOK, $STTK

AI, Biologics, and Quantum Medicine Are Fueling a New Wave of Market Movers

Healthcare and biotechnology remain especially active and offer asymmetric upside potential, as companies pursue international expansion, strategic refinancing, AI-driven operational efficiency, and next-generation pharmaceutical technologies. $TGNT, $SPRC, $WGRX, $ATPC, $SNYR, $PHR

Innovation Igniting into High-Growth Spotlight

As capital continues flowing into high-growth sectors tied to artificial intelligence, biotechnology, diagnostics, and defense technology, several emerging companies are rapidly capturing investor attention through financings, acquisitions, regulatory approvals, and platform expansion strategies. $SBFM, $TGNT, $CODX, $JUNS, $VIDA, $QUCY, $GFS, $GOOG, $MSFT, $NVDA

Biotech and Biologics Break Out: These Tiny Stocks Are Suddenly Dominating the Market Conversation

Emerging biotech and biologics names exploded onto traders’ radar Wednesday as a wave of clinical milestones, regulatory momentum, strategic acquisitions, and high-volume technical breakouts fueled aggressive speculation across the sector. $HCWB, $TGNT, $KBLB, $SLS, $RKDA, $ROIV, $SLXN

Biologics Market Momentum Accelerates Across Healthcare, AI, And Global Medical Tourism

The biologics sector is rapidly emerging as one of the most closely watched growth stories in healthcare as breakthroughs in immunotherapy, regenerative medicine, cell engineering, and AI-assisted drug development continue reshaping investor sentiment. Unlike traditional pharmaceutical compounds, biologics leverage complex biological systems to target diseases with greater specificity, opening new opportunities in cancer, autoimmune disorders, rare diseases, and regenerative therapies. $HCWB, $TGNT, $MRNA, $REGN

Chasing the Next Explosive Small-Cap Run

Risk appetite came roaring back and several companies standing out, as market participants rotated heavily into sectors tied to transformative technologies and high-growth macro trends. $TGNT, $QUCY, $AEHL, $TDIC, $WGRX, $ERNA, $SLS, $WHWK

Wall Street’s Risk-On Frenzy Returns

Among the session’s standout movers were Quantum Computing, which blasted through more than $1 billion in trading volume after reporting massive revenue growth and expanding its quantum-photonics footprint. Meanwhile, speculative traders also rotated heavily into AI-linked names including Dreamland Limited and media turnaround story BuzzFeed, both of which are holding onto substantial gains throughout the session. $TGNT, $QUBT, $BZFD, $TDIC, $HTCO, $MGNX, $CNCK, $VSTS

Healthcare Disruption, AI Biologics, and Wall Street Upgrades Ignite a Midday Market Surge

Healthcare innovators are pushing the markets today. $TGNT, $AGL, $ATRA, $ASBP

Totaligent, Inc. operates as a technology company, which provides AI-powered person-based digital marketing services for companies and individuals. The firm's digital marketing platform allows organizations to use and unlock owned and acquired data to market their products, services, and brands. Its platform leverages big data across multiple proprietary platforms including email, SMS, social media, programmatic advertising, short-code, and push notification to deliver micro-targeted person-based digital marketing and brand awareness for organizations, both large and small. The company was founded by Charles Bingham on June 24, 1988 and is headquartered in Boca Raton, FL.

Totaligent Inc

Neutral Sentiment

$UBER only

$INTC only

Both $UBER and $INTC

Neither

Nancy Pelosi recently disclosed trades in both Uber ($UBER) and Intel ($INTC) - are you following her into either? Cast your vote below.

Are you following Nancy Pelosi into her latest trades - Uber ($UBER) and Intel ($INTC)?

Current Price	$0.014
Prev Close	$0.0133
Open	$0.0122
Dividend Yield	0.00%
50-Day Moving Average	$0.0159
Beta	0.23
Avg. Volume	1.43M
PE Ratio	-5.40

52-Week High	$0.056
52-Week Low	$0.01
Market Capitalization	$5.09M
EPS (Annual)	-$0.0036
Price to Book	-1.35
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

TGNTTotaligent Inc

Latest TGNT News